

ROSALIND ADVISORS, INC. - Rosalind Capital Partners L.P.


























































		Home
	



		About
	



		Contact
	

















info@rosalindcap.com







Copyright © 2015
















✕






Rosalind Master Fund L.P. - ROSALIND ADVISORS, INC.


























































		Home
	



		About
	



		Contact
	



















info@rosalindcap.com



Contact












Founded by Gil Aharon and Steven Salamon, Rosalind advises three biotech hedge funds for accredited and qualified investors only:﻿Rosalind Capital Partners L.P. (Canadian)Rosalind Master Fund L.P. (U.S.)Rosalind Offshore Fund (offshore investors)﻿For more information and to see if you qualify, please email: info@rosalindcap.com







Copyright © 2015
















✕






Rosalind Advisors Inc: Company Profile - Bloomberg



































































  









Feedback























rosalind advisors inc
Private Company









Company Profile
Sector: Financials
Industry: Asset Management
Sub-Industry: Wealth Management
Rosalind Advisors Inc operates as an investment advisory company. The Company offers capital management, hedge funds, investment strategies, financial planning, and advisory services. Rosalind Advisors serves customers in Canada.




Corporate Information
Address:

175 Bloor Street East
Suite 807, South Tower
Toronto, ON M4W 3R8
Canada


Phone:
1-416-888-7606


Fax:
-


Web url:
www.rosalindcap.com























From The Web












Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data




































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











Company Profile : Rosalind Advisors, Inc.
































































Globe Investor  | Report on Business |  Globe Wealth






















 

Search






Funds
Stock
News























































Home
ProStation
Clients

Client List
Add a Client
Client Portfolios
Client Planners
Presentations


News

Advisor Insights
Advisor Context
Retirement Planning

Invest With Confidence
News & Columnists


Mutual Funds

Fund Codes & Fees
Top Movers
Fund Profiles




Stocks

Gainers
Losers
Most Actives
New High/Low
Current Surprises
Broker Estimates
Company Snapshots


Rates
Reports
Tools

Fund List
Stock List
Filters
Charts


Support

Contact Us
Test Drive
Help
Account
Preferences














Rosalind Advisors, Inc.
































Head Office: 

175 Bloor Street East

Suite 807, South Tower

Toronto, ON, M4W3R8





Toll Free:


Phone:


Fax:


E-mail: 
info@rosalindcap.com



Total Net Assets of funds listed on GLOBEfund.com*:
$21.57Million
CND

Rank of Total Net Assets:
156








Fund Profiles 






Extras 








Rosalind









Fund Report




Review and compare the current price and performance of all Rosalind Advisors, Inc.











More Information about the Company Profiles 













Many fund companies have offices across the country, as well as local telephone and fax numbers. Call the number on this page to find out.Click one of the Fund Profiles for detailed performance data and a history of that particular fund. Under the heading 'Extras' on the right hand side of the screen are links to further information related to this fund company. *Total Net Assets is the sum of net assets of each fund listed on globefund.com under management by the fund company.Rank is determined by sorting all fund companies in our database by the value of total net assets under management by the fund company. The fund company with the greatest value of total net assets under management receives a rank of 1, the next greatest receives a rank of 2, and so forth.









On-line:
Help
| Contact Us
| Globe Plus Subscription
| Registration

Advertise:
Advertise With Us
| Newspaper
| Magazines
| Online
| Marketing Solutions Group
| Media Central
| Classifieds

 © Copyright  The Globe and Mail Inc. All Rights Reserved.

AdChoices
| Privacy Policy
| Terms & Conditions
| Disclaimer

The Globe and Mail, 351 King Street East, Suite 1600, Toronto, ON  Canada M5A 0N1Phillip Crawley, Publisher














Rosalind Advisors, Inc. - Relationship Science



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Rosalind Advisors, Inc.



Overview
In The News Executives & Employees Paths
Holdings & Top Positions



Rosalind Advisors, Inc.



 OVERVIEW



Date Founded


2006




Headquarters


175 Bloor Street East, Suite 807, Toronto, On M4w 3r8




Industries


Hedge Funds

Investment Services & Portfolio Management




Company Description


Rosalind Advisors focuses on the life sciences sector




Website


http://www.rosalindcap.com






 In The News
          See more






See full news coverage and complete stories with RelSci Professional.

Create Your News Feed








See  More 





 Executives & Employees



Steven Alexander Salamon

Founder & President




Gilad Shevah Aharon

Portfolio Manager






 Paths to Rosalind Advisors, Inc.



                        Rosalind Advisors, Inc.                    




 You



 Connections via Relationship Science



 Rosalind Advisors, Inc.






Sync your contacts to see how you can connect with Rosalind Advisors, Inc..

Start My Free Trial ➤








See  More 


 


 Holdings & Top Positions






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 



You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.















Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤

















Rosalind Advisors, Inc.  - Current Holdings - Fintel.io

































Rosalind Advisors, Inc. 







Current Holdings (from 13F, 13D)


InvestorRosalind Advisors, Inc. 
Current Positions5


Rosalind Advisors, Inc.  has disclosed 5 total holdings in their latest SEC filings.
        
        
            
                This investor has not filed a 13F, which indicates it has under $100M in Assets Under Management (AUM).
            
        
        
        
        
        
            Rosalind Advisors, Inc. 's top industries are
            
                "Chemicals And Allied Products" (sic 28)
                ,
                 and 
            
                "Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks" (sic 38)
                
                
            .
        
    

Overview
SEC Filings
13D/13G
Predictive Value









All Rosalind Advisors, Inc.  holdings are listed in the following table.
                This data is sourced from 13D/13G, and 13F filings. Green rows indicate new positions. Red rows indicate closed positions.



Add This Fundto your dashboard



This is a list of 13D and 13G filings made since the last quarterly 13F report (if any).



File DateFormSecurity

PrevShares
CurrentShares
Change(Percent)
Prev Value(x$1000)
Current Value(x$1000)
Change(Percent)




2017‑07‑24
SC 13G
RPRX / Repros Therapeutics, Inc.

*

2,105,626






2017‑04‑07
SC 13G
PSDV / pSivida Corp.

*

2,126,800






2017‑04‑07
SC 13G/A
TNXP / Tonix Pharmaceuticals Holding Corp.

*
2,220,055
594,077
-73.24





2017‑03‑29
SC 13G/A
ZSAN / Zosano Pharma Corporation

*
2,083,100
2,083,100
0.00





2016‑02‑16
SC 13G/A
BIOD / Biodel, Inc.

*
3,592,889
590,590
-83.56















Fintel IR - Find the Right Investors for Your Company, Instantly!
        Fintel IR combines the comprehensive Fintel ownership database with machine learning to
        provide advanced tools to make investor outreach fast and easy.
        Learn more now!
















From the Blog


                How To Launch a Hedge Fund

                    The Piotroski Score




























ROSALIND ADVISORS, INC. SC 13G Filing Concerning RPRX on 2017-07-20  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active


















Schedule  13G















Filed by:


					ROSALIND ADVISORS, INC.
				


Total Shares:

                          2,105,626
			


Subject Company:


					Repros Therapeutics Inc.
                  -
                  View Complete Ownership History

          Backtest
        



Filed as of Date:
07/24/2017


Event Date:
07/20/2017


Overall % Ownership:
5.7


Reporting Persons



Name
SoleVoting Power
SharedVoting Power
SoleDispositive Power
SharedDispositive Power
AggregateAmount Owned
Percentof class


Rosalind Advisors, Inc
0
2,105,626
0
2,105,626
2,105,626
5.7%


Steven Salamon
0
2,105,626
0
2,105,626
2,105,626
5.7%


Rosalind Master Fund LP
0
627,151
0
627,151
627,151
1.7%


Rosalind Capital Partners LP
0
1,478,475
0
1,478,475
1,478,475
4.0%





					View Original Filing on Edgar's
				


Raw Filing Contents
0001019056-17-000620.txt : 20170724
0001019056-17-000620.hdr.sgml : 20170724
20170724165439
ACCESSION NUMBER:		0001019056-17-000620
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20170724
DATE AS OF CHANGE:		20170724
GROUP MEMBERS:		ROSALIND ADVISORS, INC.
GROUP MEMBERS:		ROSALIND CAPITAL PARTNERS L.P.
GROUP MEMBERS:		ROSALIND MASTER FUND L.P.
GROUP MEMBERS:		STEVEN SALAMON

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REPROS THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000897075
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				760233274
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-52909
		FILM NUMBER:		17978723

	BUSINESS ADDRESS:	
		STREET 1:		2408 TIMBERLOCH PL
		STREET 2:		SUITE B-7
		CITY:			WOODLANDS
		STATE:			TX
		ZIP:			77380
		BUSINESS PHONE:		2817193400

	MAIL ADDRESS:	
		STREET 1:		2408 TIMBERLOCH PLACE B-7
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77380

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REPROS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20060503

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZONAGEN INC
		DATE OF NAME CHANGE:	19930208

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rosalind Advisors, Inc.
		CENTRAL INDEX KEY:			0001622627
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		175 BLOOR STREET EAST
		STREET 2:		SUITE 1316, NORTH TOWER
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4W 3R8
		BUSINESS PHONE:		4168887606

	MAIL ADDRESS:	
		STREET 1:		175 BLOOR STREET EAST
		STREET 2:		SUITE 1316, NORTH TOWER
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4W 3R8


SC 13G
1
repros_13g.htm
SC 13G


 
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G

Under
the Securities Exchange Act of 1934 
Repros Therapeutics
Inc.
 


(Name
of Issuer)
Common Shares
 


(Title
of Class of Securities)
76028H209 
 


(CUSIP
Number)
July 20, 2017
 


(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:


o
Rule 13d-1(b)

x
Rule 13d-1(c)

o
Rule 13d-1(d)


*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in
a prior cover page.
The information
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
 

 



 
 
 

CUSIP
                                         No. 76028H209 
13G
Page
                                                                     2 of 9 Pages





 
 
 
 
 
 
 
 

1.
 
NAMES
    OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  Rosalind Advisors, Inc.
 
 

2.
 
CHECK
    THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    o
    (b)    o
 
 

3.
 
SEC
    USE ONLY  
 
 

4.
 
CITIZENSHIP
    OR PLACE OF ORGANIZATION   ONTARIO, CANADA
 
 

NUMBER
                                                                                                                                                                OF
                                                                                                                                                                SHARES
                                                                                                                                                                BENEFICIALLY
                                                                                                                                                                OWNED
                                                                                                                                                                BY
                                                                                                                                                                EACH
                                                                                                                                                                REPORTING
                                                                                                                                                                PERSON
                                                                                                                                                                WITH
 
 
 

5.
 
SOLE
    VOTING POWER   0

6.
 
SHARED
    VOTING POWER    2,105,626

7.
 
SOLE
    DISPOSITIVE POWER   0

8.
 
SHARED
    DISPOSITIVE POWER    2,105,626

 
 
 
 
 

9.
 
AGGREGATE
    AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

     2,105,626
 
 

10.
 
CHECK
    IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ¨
 
 

11.
 
PERCENT
    OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
    5.7%1
 
 

12.
 
TYPE
    OF REPORTING PERSON (see instructions)   CO
 
 

 
 
1 This percentage is calculated based upon 36,910,570 shares of the Issuer’s common stock outstanding
as of July 20, 2017.

 
 



 
 
 

CUSIP
                                         No. 76028H209 
13G
Page
                                                                     3 of 9 Pages




 
 
 
 
 
 
 
 

1.
 
NAMES
    OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  Steven Salamon
 
 

2.
 
CHECK
    THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    o
    (b)    o
 
 

3.
 
SEC
    USE ONLY  
 
 

4.
 
CITIZENSHIP
    OR PLACE OF ORGANIZATION   ONTARIO, CANADA
 
 

NUMBER
                                                                                                                                                                OF
                                                                                                                                                                SHARES
                                                                                                                                                                BENEFICIALLY
                                                                                                                                                                OWNED
                                                                                                                                                                BY
                                                                                                                                                                EACH
                                                                                                                                                                REPORTING
                                                                                                                                                                PERSON
                                                                                                                                                                WITH
 
 
 

5.
 
SOLE
    VOTING POWER   0

6.
 
SHARED
    VOTING POWER    2,105,626

7.
 
SOLE
    DISPOSITIVE POWER   0

8.
 
SHARED
    DISPOSITIVE POWER    2,105,626

 
 
 
 
 

9.
 
AGGREGATE
    AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

     2,105,626
 
 

10.
 
CHECK
    IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ¨
 
 

11.
 
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
 5.7%2 
 
 

12.
 
TYPE
    OF REPORTING PERSON (see instructions)   IN
 
 

 

 
2
This percentage is calculated based upon 36,910,570 shares of the Issuer’s common stock outstanding
as of July 20, 2017.


 
 



 
 
 

CUSIP
                                         No. 76028H209 
13G
Page
                                                                     4 of 9 Pages




 
 
 
 
 
 
 
 

1.
 
NAMES
    OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  Rosalind Master Fund L.P.
 
 

2.
 
CHECK
    THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    o
    (b)    o
 
 

3.
 
SEC
    USE ONLY  
 
 

4.
 
CITIZENSHIP
    OR PLACE OF ORGANIZATION   CAYMAN ISLANDS
 
 

NUMBER
                                                                                                                                                                OF
                                                                                                                                                                SHARES
                                                                                                                                                                BENEFICIALLY
                                                                                                                                                                OWNED
                                                                                                                                                                BY
                                                                                                                                                                EACH
                                                                                                                                                                REPORTING
                                                                                                                                                                PERSON
                                                                                                                                                                WITH
 
 
 

5.
 
SOLE
    VOTING POWER   0

6.
 
SHARED
    VOTING POWER   627,151

7.
 
SOLE
    DISPOSITIVE POWER   0

8.
 
SHARED
    DISPOSITIVE POWER   627,151

 
 
 
 
 

9.
 
AGGREGATE
    AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

    627,151
 
 

10.
 
CHECK
    IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ¨
 
 

11.
 
PERCENT
    OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
    1.7%3
 
 

12.
 
TYPE
    OF REPORTING PERSON (see instructions)   PN
 
 

 
 
3 This percentage is calculated based upon 36,910,570 shares of the Issuer’s common stock outstanding as
of July 20, 2017.

 
 



 
 
 

CUSIP
                                         No. 76028H209 
13G
Page
                                                                     5 of 9 Pages




 
 
 
 
 
 
 
 

1.
 
NAMES
    OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  Rosalind Capital Partners L.P.
 
 

2.
 
CHECK
    THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    o
    (b)    o
 
 

3.
 
SEC
    USE ONLY  
 
 

4.
 
CITIZENSHIP
    OR PLACE OF ORGANIZATION   ONTARIO, CANADA
 
 

NUMBER
                                         OF
                                         SHARES
                                         BENEFICIALLY
                                         OWNED BY
                                         EACH
                                         REPORTING
                                         PERSON WITH




5.
 
SOLE
    VOTING POWER   0

6.
 
SHARED
    VOTING POWER   1,478,475

7.
 
SOLE
    DISPOSITIVE POWER   0

8.
 
SHARED
    DISPOSITIVE POWER   1,478,475







9.
 
AGGREGATE
    AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

    1,478,475
 
 

10.
 
CHECK
    IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ¨
 
 

11.
 
PERCENT
    OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   4.0%4
 
 

12.
 
TYPE
    OF REPORTING PERSON (see instructions)   PN
 
 

 

 
4 This percentage is calculated based upon 36,910,570 shares of the Issuer’s common stock outstanding as
of July 20, 2017. 

 
 



 
 
 
 
 

CUSIP No. 76028H209 
 
13G
 
Page
    6 of 9 Pages

 
 
 
 
 

Item
1.
 


 
(a)
Name of
                                         Issuer: REPROS THERAPEUTICS INC.


 
 
 

 
(b)

Address of Issuer’s Principal
Executive Offices
2408 Timberloch Place, Suite B-7
The Woodlands, TX 77380, United States



 
 
 

Item
2.
 


 
(a)
Name
                                         of Person Filing

Rosalind
        Advisors, Inc. (“Advisor” to RCP & RMF)
Rosalind
        Master Fund L.P. (“RMF”)
Rosalind
        Capital Partners L.P. (“RCP”)
Steven
        Salamon (“President”)
Steven
        Salamon is the portfolio manager of the Advisor which advises RCP & RMF.

 
 
 

 
(b)
Address
                                         of the Principal Office or, if none, residence
                                         Rosalind Advisors, Inc.
175
        Bloor Street East
Suite 1316, North Tower
Toronto,
        Ontario
M4W
        3R8 Canada
 
Rosalind
        Master Fund L.P.
P.O.
        Box 309
Ugland
        House, Grand Cayman
KY1-1104,
        Cayman Islands
 
Rosalind
        Capital Partners L.P.
175
        Bloor Street East
Suite 1316, North Tower
Toronto,
        Ontario
M4W
        3R8 Canada
 
Steven
        Salamon
175
        Bloor Street East

Suite 1316, North Tower
Toronto,
Ontario
M4W
        3R8 Canada

 
 
 

 
(c)
Citizenship
Rosalind Advisors, Inc.: Ontario, Canada
Rosalind
Master Fund L.P.: Cayman Islands 
Rosalind
Capital Partners L.P.: Ontario, Canada 
Steven
        Salamon: Ontario, Canada


 
 
 

 
(d)
Title of Class
    of Securities
    Common Stock

 
 
 

 
(e)
CUSIP Number
    76028H209 


 
 




 
 
 
 

CUSIP No. 76028H209 
 
13G
 
Page
    7 of 9 Pages

 
 
 
 
 


Item 3.If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
  



 
(a)
o
Broker
    or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 
 
 
 

 
(b)
o
Bank as defined
    in section 3(a)(6) of the Act (15 U.S.C. 78c).

 
 
 
 

 
(c)
o
Insurance company
    as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 
 
 
 

 
(d)
o
Investment company
    registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 
 
 
 

 
(e)
o
An investment
    adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 
 
 
 

 
(f)
o
An employee benefit
    plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 
 
 
 

 
(g)
o
A parent holding
    company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 
 
 
 

 
(h)
o
A savings associations
    as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 
 
 
 

 
(i)
o
A church plan
    that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940
    (15 U.S.C. 80a-3);

 
 
 
 

 
(j)
o
Group, in accordance
    with §240.13d-1(b)(1)(ii)(J).

 
 
 
 


Item 4.Ownership.
 
  

Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.


 
 
 
 
 

 
(a)
 
Amount
                                         beneficially owned:  
 
Rosalind Master Fund
        L.P. is the record owner of 627,151 shares of common stock.
Rosalind Capital Partners
        L.P. is the record owner of 1,478,475 shares of common stock.
Rosalind
        Advisors, Inc. is the investment advisor to RCP and RMF and may be deemed to be the beneficial owner of shares held by
        RCP and RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares
        held by RCP and RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.

 
 
 
 
 

 
(b)
 
Percent
                                         of class:  
Rosalind
        Advisors, Inc. – 5.7%
Rosalind
        Master Fund L.P. – 1.7%
Rosalind
        Capital Partners L.P. – 4.0%
Steven
        Salamon – 5.7%

 
 
 
 
 


 
 





 
 
 
 

CUSIP No. 76028H209 
 
13G
 
Page
    8      of 9 Pages

 
 
 
 
 



 
 
 
 
 

 
(c)                        
 
 Number
    of shares as to which the person has:  

 
 
 
 

 
 
 
(i)
Shared
                                         power to vote or to direct the vote  
Rosalind
        Advisors, Inc. –  2,105,626
Rosalind
        Master Fund L.P. – 627,151
Rosalind
        Capital Partners L.P. – 1,478,475
Steven
        Salamon –  2,105,626

 
 
 
 
 

 
 
 
(ii)
Sole
    power to dispose or to direct the disposition of  – 0

 
 
 
 
 

 
 
 
(iii)
Shared
                                         power to dispose or to direct the disposition of  
Rosalind
        Advisors, Inc. –  2,105,626
Rosalind
        Master Fund L.P. – 627,151
Rosalind
        Capital Partners L.P. – 1,478,475
Steven
        Salamon –  2,105,626

 
 
 
 
 
 
 
 
 
 

Instruction.
For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

Item 5.Ownership
of Five Percent or Less of a Class.
 
  

If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following  o. 
Instruction.
Dissolution of a group requires a response to this item.

Item 6.Ownership
of More than Five Percent on Behalf of Another Person.
 
  


Item
                           7– 9.Not
Applicable


 
 





 
 
 
 

CUSIP No. 76028H209 
 
13G
 
Page
    9 of 9 Pages

 
 
 
 
 


Item 10.Certification.



 
 
 
 

 
 
 
By
    signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
    are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
    and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


 
 
 
 


After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.


 
 

 
7/24/2017


 
 Date

 
 

 
/s/ Steven Salamon

 
 Signature

 
 

 
Steven
    Salamon/President Rosalind Advisors, Inc.

 
Name/Title

 








Elevate your investments
Try it for free






















Rosalind Advisors, Inc.




 

 

Institutions
People
Ownership
Securities
Calendar
Tracking
Reports
Admin
BD Mail













Contact Information



Phone



Address



Website






Portfolio Information



Reported Total Holdings (USD)



Stated Total Holdings



Reported Equity Assets



Reported Fixed Income Assets



Reported Cash



Reported Other



Portfolio Turnover



FI Portfolio Turnover






General Information



Overview 



Analytics 



People 



Lists 



Holding 



Funds 



Action 



Asset Class 



InstitutionType



Style 



Dominant Orientation 






Application Functionality



Detailed Investor Prospecting



Intuitive CRM



Robust Analytics



Integrated Communication Tools









Home > Institutions > Sample profile for Rosalind Advisors, Inc.
 









Sample Profile for Rosalind Advisors, Inc. 

 





 










Activity







Quick Profile











 Primary Contact(s): 
 Designated Primary Contact


























Location
Toronto, Canada  





Fix Data






Address
Street Address, Toronto,Ontario xxxxx, Canada
Phone
+x xxx-xxx-xxxx


Website
Request Now
Fax
+x xxx-xxx-xxxx


Asset Class
Request Now
 











Institution Type
Request Now
 


Style
Request Now
 


Dominant Orientation
Request Now
 


Equity Portfolio Turnover
xx%
 


Reported Total Holdings (USD, mm) 3/9/2011
xxx,xxx.xx
 


Stated Total Holdings (USD, mm)
x,xxx,xxx.xx
 




Portfolio Breakdown










Reported Equity Assets (USD, mm) 3/9/2011
xxx,xxx.xx


Reported Fixed Income Assets (USD, mm) 2/28/2011
xx,xxx.xx


Reported Cash (USD, mm)
xx,xxx.xx


Reported Other (USD, mm)
x,xxx.xx


 


 




Asset Allocation
















































Add to Institution List









Remove from Lists









Briefing Book Report









Edit Institution









Disable BD Auto Update









Merge Institution






















































Overview
    Provides a general overview of the entity; including regional offices, M&A history and date founded.
Equity Investment Approach
Provides a detailed overview of how the entity approaches investment in the equity markets; including funds of note, strategy and other critical information. 
Fixed Income Investment Approach
Provides a detailed overview of how the entity approaches investment in the fixed income markets; including funds of note, strategy and other critical information. 











  


 


   


















Ipreo's BD product suite offers access to the most accurate and comprehensive database covering the global investment community in the industry.  With solutions built specifically to cater to the workflows of capital markets and investor relations professionals, Ipreo's BD applications include global multi-asset class institutional contact data, investor profiles, and robust ownership information - all powered by the industry-leading Bigdough database - over 115,000 contacts at more than 23,000 financial institutions globally, buy-side and sell-side, equity and fixed income, including 16,000 hedge-fund contacts. This database is seamlessly integrated with advanced investor screening capabilities, intuitive search features, and powerful CRM and messaging functions. Ipreo's mission is to ensure our clients establish personal relationships with the right investors and manage those relationships effortlessly. 



Home > Erik G. Mermagen
 









Sample Contact 







 










Activity







Mail







Quick Profile








 






















Job Function
Portfolio Manager 





Fix Data






Institution Name
Rosalind Advisors, Inc.

 


Address
Request Now  
 


Mailling address
Request Now 
 


Email


Sales@ipreo.com




 


Telephone
+xx xx-xxxx-xxxx
 
Fax
+xx xx-xxxx-xxxx
 







 Provides an overview of the firm that the contact is associated with. 







































Designate Primary









Add to Contact List









Add to Institution List









Remove From My Contacts









Remove from Lists









Export Vcard









Edit Contact









Exclude From Mail









Disable BD Auto Update









Merge Contact









Briefing Book Report









Sync with Outlook









































Education
Educational background on the contact.


Biography

                                            Overview of the contact's current role, historical employment and  other important background information.


Scouting Report
Provides unique insight into fund managers' decision-making criteria, and gives detailed information about your investors and marketplace.


Funds Managed
Provides a list of the funds managed by the contact.  
											 






  


 


   














Ipreo's BD product suite offers access to the most accurate and comprehensive database covering the global investment community in the industry.  With solutions built specifically to cater to the workflows of capital markets and investor relations professionals, Ipreo's BD applications include global multi-asset class institutional contact data, investor profiles, and robust ownership information - all powered by the industry-leading Bigdough database - over 115,000 contacts at more than 23,000 financial institutions globally, buy-side and sell-side, equity and fixed income, including 16,000 hedge-fund contacts. This database is seamlessly integrated with advanced investor screening capabilities, intuitive search features, and powerful CRM and messaging functions. Ipreo's mission is to ensure our clients establish personal relationships with the right investors and manage those relationships effortlessly. 
 
 
 
 
 
 








© 2011 
            Ipreo Holdings LLC. All rights reserved. Patents pending. 

 Third Party Data 
 Disclaimer 
 Privacy Policy 
 Terms of Use 











Rosalind Advisors, Inc. disclosed a new stake in Repros Therapeutics, Inc. in a filing on July 20, 2017


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology














        Rosalind Advisors, Inc. disclosed a new stake in Repros Therapeutics, Inc. in a filing on July 20, 2017    























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 

          Jul 27, 2017                         - RelSci Data Update                

          Institutional Holdings Changes      




Background Information:


Rosalind Advisors, Inc. »
Rosalind Advisors focuses on the life sciences sector




In The News:




                            Rosalind Advisors, Inc. disclosed a new stake in Tonix Pharmaceuticals Holding Corp. in a filing on April 5, 2017                            


                            April 14, 2017  •  RelSci                        





                            Rosalind Advisors, Inc. disclosed a new stake in Zosano Pharma Corp. in a filing on March 28, 2017                            


                            April 14, 2017  •  RelSci                        





                            Rosalind Advisors, Inc. disclosed a new stake in pSivida Corp. in a filing on April 5, 2017                            


                            April 13, 2017  •  RelSci                        









Rosalind Advisors, Inc. »
Rosalind Advisors focuses on the life sciences sector






In The News:




 


                                                    Rosalind Advisors, Inc. disclosed a new stake in Tonix Pharmaceuticals Holding Corp. in a filing on April 5, 2017                                                





                                     April 14, 2017  •  RelSci                                





 


                                                    Rosalind Advisors, Inc. disclosed a new stake in Zosano Pharma Corp. in a filing on March 28, 2017                                                





                                     April 14, 2017  •  RelSci                                





 


                                                    Rosalind Advisors, Inc. disclosed a new stake in pSivida Corp. in a filing on April 5, 2017                                                





                                     April 13, 2017  •  RelSci                                















You've found a premium RelSci Pro feature!



Connect to Individuals and Organizations In This Story

Upgrade to RelSci Pro to easily sync your contacts and see how you can reach the people and organizations featured in this article.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now










Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤
















ROSALIND ADVISORS, INC. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      ROSALIND ADVISORS, INC.
                    

•   TORONTO, A6
                      
How do I update this listing?




                                             Rosalind Advisors is based out of Toronto.    WhaleWisdom has at least 10 13D/G filings in our database for Rosalind Advisors.
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from ROSALIND ADVISORS, INC., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




rosalind advisors, inc.


175 BLOOR STREET EAST

TORONTO
A6
                                                        
                                                    M4W 3R8


              Business Phone:
              4168887606







Recent SEC Filings




SC 13G filed on 07/24/2017
SC 13G filed on 04/07/2017
SC 13G/A filed on 04/07/2017
SC 13G/A filed on 03/29/2017
SC 13G filed on 11/30/2016
SC 13G filed on 11/16/2016
SC 13G/A filed on 02/16/2016
SC 13G filed on 08/26/2015
SC 13G/A filed on 04/23/2015
SC 13G filed on 10/24/2014











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





Zosano Pharma Corp (ZSAN)


      HEALTH CARE
    

      2,083,100
    

      3,916,228.00
    

      1
    

      13G
    

      2017-03-28
    



Psivida Corp. ADR (PSDV)


      HEALTH CARE
    

      2,126,800
    

      3,466,684.00
    

      2
    

      13G
    

      2017-04-05
    



Tonix Pharmaceuticals Holding Corp. (TNXP)


      MATERIALS
    

      594,077
    

      2,293,137.22
    

      3
    

      13G
    

      2017-04-05
    



Repros Therapeutics Inc. (RPRX)


      HEALTH CARE
    

      2,105,626
    

      842,250.40
    

      4
    

      13G
    

      2017-07-20
    











Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















